1. Inflammation/Immunology

Inflammation/Immunology

The diseases caused by disorders of the immune system fall into two broad categories: immunodeficiency and autoimmunity. Immunotherapy is also often used in the immunosuppressed (such as HIV patients) and people suffering from other immune deficiencies or autoimmune diseases. This includes regulating factors such as IL-2, IL-10, IFN-α. Infection with HIV is characterized not only by development of profound immunodeficiency but also by sustained inflammation and immune activation. Chronic inflammation as a critical driver of immune dysfunction, premature appearance of aging-related diseases, and immune deficiency.

Cat. No. Product Name CAS No. Purity Chemical Structure
  • HY-P990664
    Anti-Melanotransferrin/CD228 Antibody 98%
    Anti-Melanotransferrin/CD228 Antibody (SC-005 antibody) is a humanized antibody expressed in CHO cells, targeting Melanotransferrin/CD228. Anti-Melanotransferrin/CD228 Antibody carries a huIgG1 heavy chain and a huκ light chain, with a predicted molecular weight (MW) of 145.16 kDa. The isotype control for Anti-Melanotransferrin/CD228 Antibody can refer to Human IgG1 kappa, Isotype Control (HY-P99001).
    Anti-Melanotransferrin/CD228 Antibody
  • HY-P990665
    Anti-SLAMF6 Antibody (h20F3ec) 98%
    Anti-SLAMF6 Antibody (h20F3ec) (SGN-CD352A antibody) is a human-derived antibody expressed in CHO targeting SLAMF6/CD352. Anti-SLAMF6 Antibody (h20F3ec) has a muIgG1 type heavy chain and a huκ type light chain, with a predicted molecular weight (MW) of 145.9 kDa. The isotype control for Anti-SLAMF6 Antibody (h20F3ec) can be referenced as Human IgG1 kappa, Isotype Control (HY-P99001).
    Anti-SLAMF6 Antibody (h20F3ec)
  • HY-P990668
    TOL-101 98%
    TOL-101
  • HY-P990674
    VB1-050 98%
    VB1-050 is a human antibody expressed in CHO cells, targeting SLC2A8. VB1-050 is composed of huIgG1 heavy chains and huκ light chains, with a predicted molecular weight (MW) of 150 kDa. The isotype control for VB1-050 can refer to Human IgG1 kappa, Isotype Control (HY-P99001).
    VB1-050
  • HY-P990677
    VLST-002 98%
    VLST-002 is a humanized antibody expressed in CHO cells, targeting CCL5/RANTES. VLST-002 has a huIgG1 heavy chain and a huκ light chain, with a predicted molecular weight (MW) of 150 kDa. The isotype control for VLST-002 can refer to Human IgG1 kappa, Isotype Control (HY-P99001).
    VLST-002
  • HY-P990678
    Vonlerizumab 1638935-72-4 98%
    Vonlerizumab is a CHO-expressed humanized antibody targeting TNFRSF4/OX40/CD134. Vonlerizumab carries a huIgG1 heavy chain and a huκ light chain, with a predicted molecular weight (MW) of 145.22 kDa. The isotype control for Vonlerizumab can refer to Human IgG1 kappa, Isotype Control (HY-P99001).
    Vonlerizumab
  • HY-P990683
    Satumomab 144058-40-2 98%
    Satumomab is an anti-TAG-72 IgG4-G2a κ monoclonal antibody.
    Satumomab
  • HY-P990684
    Tacatuzumab 98%
    Tacatuzumab is an anti-AFP (alpha-fetoprotein protein) human IgG1 κ monoclonal antibody. Recommend Isotype Controls: Human IgG1 kappa, Isotype Control (HY-P99001).
    Tacatuzumab
  • HY-P990686
    Ispectamab 98%
    Ispectamab is an anti-TNFRSF17 human IgG1 κ monoclonal antibody. Recommend Isotype Controls: Human IgG1 kappa, Isotype Control (HY-P99001).
    Ispectamab
  • HY-P990692
    Ciduvectamig 2412587-62-1 98%
    Ciduvectamig is an anti-CD3E/TMEFF2 human IgG4 κ monoclonal antibody. Recommend Isotype Controls: Human IgG4 (S228P) kappa, Isotype Control (HY-P99003).
    Ciduvectamig
  • HY-P990693
    Tarperprumig 2630946-41-5 98%
    Tarperprumig is an anti-ALB/CFP monoclonal antibody composed of 2 heavy chain variable regions linked together.
    Tarperprumig
  • HY-P990695
    Lunaxafusp 2642197-17-7 98%
    Lunaxafusp is an anti-ERBB2 scFv-heavy-κ monoclonal antibody composed of a single chain variable fragment, an antibody heavy chain, and a kappa antibody light chain.
    Lunaxafusp
  • HY-P990696
    Resugosbart 2647412-09-5 98%
    Resugosbart is an anti-SOST human IgG4 κ monoclonal antibody. Recommend Isotype Controls: Human IgG4 (S228P) kappa, Isotype Control (HY-P99003).
    Resugosbart
  • HY-P990697
    Anvatabart 2636710-06-8 98%
    Anvatabart is an anti-ERBB2 human IgG1 κ monoclonal antibody. Recommend Isotype Controls: Human IgG1 kappa, Isotype Control (HY-P99001).
    Anvatabart
  • HY-P990699
    Riltovetbart 2641479-65-2 98%
    Riltovetbart is a canine-derived IgG2 κ monoclonal antibody raised against Canlupfam IL13.
    Riltovetbart
  • HY-P990700
    Tobemstomig 2648839-43-2 98%
    Tobemstomig is an anti-PDCD1/LAG3 human IgG1 κ monoclonal antibody. Recommend Isotype Controls: Human IgG1 kappa, Isotype Control (HY-P99001).
    Tobemstomig
  • HY-P990704
    Rilvegostomig 2640305-01-5 99.00%
    Rilvegostomig is an anti-PDCD1/TIGIT human IgG1 κ monoclonal antibody. Recommend Isotype Controls: Human IgG1 kappa, Isotype Control (HY-P99001).
    Rilvegostomig
  • HY-P990705
    Gorivitug 2765086-18-6 98%
    Gorivitug is an anti-SARS-CoV-2 human IgG1 κ monoclonal antibody. Recommend Isotype Controls: Human IgG1 kappa, Isotype Control (HY-P99001).
    Gorivitug
  • HY-P990707
    Maplirpacept 2631667-06-4 98%
    Maplirpacept (TTI-622; PF-07901801) is a fusion protein consisting of the CD47-binding domain of human SIRPα linked to the Fc region of human IgG4. Maplirpacept enhances phagocytosis by blocking CD47.
    Maplirpacept
  • HY-P990708
    Bizaxofusp 1236019-35-4 98%
    Bizaxofusp is an anti-IL4R monoclonal antibody.
    Bizaxofusp
Cat. No. Product Name / Synonyms Application Reactivity